We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Emeis (EMEIS) EUR10

Sell:€5.41 Buy:€5.47 Change: €0.33 (6.54%)
Market closed |  Prices as at close on 25 October 2024 | Switch to live prices |
Sell:€5.41
Buy:€5.47
Change: €0.33 (6.54%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 25 October 2024 | Switch to live prices |
Sell:€5.41
Buy:€5.47
Change: €0.33 (6.54%)
Market closed |  Prices as at close on 25 October 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Orpea SA is a France-based company that is engaged in the operations of retirement homes, outpatient and rehabilitation clinics, and psychiatric care. Through its wholly owned subsidiary, Clinea, the Company also offers a range of other services, from outpatient treatment, post-operation care and physical therapy, to nursing, geriatric care, psychiatric services, and long-term care homes. The Company operates a number of wholly owned subsidiaries, including Clinea, Villers Services SA, Residence La Cheneraie SAS, Carina SA, Super Aix SCI, Emcejidey SA, Maison de Retraite Paul Cezanne SA and Inoges AG, among others. It operates through Vitalis, Senevita, Dr. Dr. Wagner group and Anavita, operator of nursing homes in the Czech Republic.

Contact details

Address:
12 Rue Jean Jaures, Puteaux Cedex
PUTEAUX
92813
France
Telephone:
+33 (1) 40781515
Website:
https://www.emeis.fr/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
EMEIS
ISIN:
FR001400NLM4
Market cap:
€819.96 million
Shares in issue:
159.08 million
Sector:
Health Care Facilities
Exchange:
Euronext Paris
Country:
France
Currency:
Euro
Indices:
Euronext Next 150

Key personnel

  • Laurent Guillot
    Chief Executive Officer, Director
  • Fabienne Dulac
    Deputy Chief Executive Officer
  • Jean-Marc Boursier
    Chief Financial Officer, Member of the Management Board
  • Fanny Barbier
    Executive Vice President of Human Resources, Member of the Management Committee, Member of the Executive Committee
  • Muriel Barneoud
    Group Executive Vice President - CSR And Quality, Member of the Management Committee, Member of the Executive Committee
  • Frederique Raoult
    Group Executive Vice President - Communications, Member of the Management Committee, Member of the Executive Committee
  • Gery Robert-Ambroix
    Group Executive Vice President - Real Estate, Member of the Management Committee, Member of the Executive Committee
  • Erik Hamann
    General Director - Germany, Member of the Management Committee, Member of the Executive Committee
  • Anton Kellner
    Chief Executive Officer, Central and Eastern Europe, Member of the Management Committee, Member of the Executive Committee
  • Pierre Krolak-Salmon
    Group Executive Vice President Medical, Member of the Management Committee, Member of the Executive Committee

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.